I always thought that steroids were the kind used by athletes and bodybuilders to pump up their performance.
Yes, they do exist and, yes they are quite dangerous, but those aren’t the kind of steroids this article is about.
This article is not for those with a weak stomach. Because Stevens-Johnson Syndrome is an ugly and sometimes deadly disease.
But if you are on Dilantin or Lamictal, I urge you to read this information.
The first Vagus Nerve Stimulator (VNS) was implanted in 1988, as a therapeutic option for medically intractable epilepsy, when elective epilepsy surgery was not appropriate.
As the number of implanted vagus nerve stimulators grows, so does the need to remove or revise the devices.
Which is a little tricky, because of the spiral stimulating electrodes, wrapped around the nerve.
Especially if the VNS treatment has proven ineffective.
And of course, what goes in, must come out.
Anyway you look at it, there’s more surgery involved.
As Americans become more concerned about quality issues with prescription medications made abroad, one company is trying to offer an additional layer of reassurance — by doing chemical analysis before dispensing drugs to patients.
After talking to a famous epileptologist, I learned that calcium is really a two-edged sword. Which surprised (and scared) me.
I’ve always read that calcium was imperative if you were taking anti-epilepsy drugs — especially Dilantin. Even if your doc “forgot” to tell you!
Long-term use of Xcopri was safe and reduced seizures by more than 90% in adults with uncontrolled focal seizures, according to results of an open-label extension study published in Neurology.
MSG can be responsible for long term neurological damage.
It’s been linked to diabetes, stroke, epilepsy, multiple sclerosis, stomach disorders, fatigue, depression, headaches and migraines, grand mal seizures, irregular or rapid heartbeat, nausea and vomiting, numbness in the fingertips, autism, ADHD, asthma-like symptoms, fibromyalgia type pain, disorientation and confusion, and degenerative disorders such as Parkinson’s and Alzheimer’s.
“Compared with 2008, costs for brand-name anti seizure meds (ASMs), rose from approximately $2,800 to $10,700 per year in 2018, while costs for generic brand ASMs dropped $800 to $460. As a result, many generic ASMs cost about 10 times less than their brand-name counterparts…”